期刊文献+

抑制骨髓基质干细胞雌激素受体β基因表达的有效序列

Construction and identification of eukaryotic expression vector of RNA interference specific for estrogen receptor beta
下载PDF
导出
摘要 背景:雌激素受体β是否参与介导骨髓间充质干细胞的增殖与分化需进一步实验论证。目的:以RNAi技术寻找和验证对大鼠骨髓基质干细胞雌激素受体β基因表达抑制的有效序列。方法:根据GeneBank数据库提供的SD大鼠雌激素受体β基因核苷酸序列,选择设计能转录小发卡结构RNA(Small hairpin RNAs,shRNA)的DNA序列。再在两条互补碱基序列的5'端分别加上BamHⅠ(GATCC)和HindⅢ(AGCTT)酶的酶切位点,最后形成两条互补的克隆入pSilencer3.1-H1载体的发夹状siRNA模板序列,进行重组载体的碱基序列测定。结果与结论:重组质粒碱基序列鉴定后,证实真核表达载构建正确。雌激素受体β特异性siRNA真核表达载体构建成功。 BACKGROUND: Whether estrogen receptor beta (ER-β) participates to mediate proliferation and differentiation of bone marrow mesenchymal stem cells is unclear.OBJECTIVE: To construct and identify a specific small interfering RNA (siRNA) suppressing estrogen receptor beta gene.METHODS: Genome sequences of ER-β gene was retrieved from Genbank and cDNA was designed coding expression of small hairpin RNAs (shRNA) for ER-β gene.It was cloned into the expression vector pSilencer 3.1-H1 into a short hairpin RNA with BamH Ⅰ,HindⅢ sticky end,terminated cognition sequence and a loop structure,followed by being cloned in pRNAT-U6.1 /Neo to construct a expression vector of ER-β-specific siRNA.At last the vector was evaluated by enzyme cutting and gene sequencing test.RESULTS AND CONCLUSION: The recombinant plasmid of RNA interference specific for ER-β identified by the restriction map completely coincided with the designs.The siRNA eukaryotic expression vector against ER-β mRNA has been successfully constructed.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第19期3459-3462,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家自然科学基金资助项目(30872913)~~
  • 相关文献

参考文献30

  • 1Mamoun Younes,Naoko Honma.Estrogen Receptor β.Arch Pathol Lab Med.2011;135:63-66.
  • 2Weitzmann MN,Pacifiei R.T cells:unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis.Ann N Y Acad Sei.2007;1 1 16:360-375.
  • 3Braidman IP,HaineyL,Batra G,et al.Localization of estrogen receptor beta protein expression in adult human bone.J Bone Miner Res.2001;16(2):214-220.
  • 4Lindberg MK,MovSrare S,Skrtic S,et al.Estrogen receptor(ER)-B reduce ER-a-regulated gene transcription.supporting a "YingYang"relationship between ER-a and ER-B in mice.Mol Endocrinol.2003;17(2):203-208.
  • 5Weiser MJ,Foradori CD,Handa RJ.Estrogen receptor beta in the brain:from form to function.Brain Res Rev.2008;57(2):309–320.
  • 6Liu L,Chirala M,Younes M.Expression of estrogen receptor-beta isoforms in Barrett's metaplasia,dysplasia and esophageal adenocarcinoma.Anticancer Res.2004;24(5A):2919–2924.
  • 7Milanesi L,Vasconsuelo A,de Boland AR,et al.Expression and subcellular distribution of native estrogen receptor beta in murine C2C12 cells and skeletal muscle tissue.Steroids.2009;74(6):489-497.
  • 8Kumar A,Klinge CM,Goldstein RE.Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.Int J Oncol.2010;36(5):1067-1080.
  • 9Abe K,Miki Y,Ono K,et al.Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer.Hum Pathol.2010;41(2):190–198.
  • 10Ali G,Donati V,Loggini B,et al.Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma.Hum Pathol.2008;39(10):1465-1473.

二级参考文献44

  • 1Yoshiji H, Kuriyama S, Hicklin DJ, et al. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in nmrine hepatocellular carcinoma cells [ J ]. Hepatology, 1999, 30(5): 1179-1186.
  • 2Wang S, Liu H, Ren L, et al. Inhibiting colorectal carcinoma growth and metastasis by expression of VEGF using RNA interference [ J ]. Neoplasia, 2008, 10(4) : 399 -407.
  • 3Maehara Y, Kakeji Y, Oda S, et al. Tumor growth patterns and biological characteristics of early gastric carcinoma[J]. Ontology, 2001, 61(2) : 102 -112.
  • 4Gruuewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization : recruitment, retention, and role of accessory cells [ J ]. Cell, 2006, 124(1) : 175 -189.
  • 5Couhas L, Chawengsaksophak K, Rossant J. Endothelial cells and VEGF in vascular development[J]. Nature, 2005, 438(7070) : 937 -945.
  • 6Cardones AR, Banez LL. VEGF inhibitors in cancer therapy[ J ]. Curr Pharm Des, 2006, 12(3) : 387 -394.
  • 7Donovan EA, Kummar S. Targeting VEGF in cancer therapy [J]. Curr Probl Cancer, 2006, 30 ( 1 ) : 7 - 32.
  • 8Giguere V, Yang N, Segui P, et al. Identification of a new class of steroid hormone receptors. Nature, 1988, 331:91-94.
  • 9Villena JA, Kralli A. ERRa: a metabolic function for the oldest orphan. Trends Endocrinol Metab, 2008, 19:269-276.
  • 10Stein RA, Chang CY, Kazmin DA, et al. Estrogen-related receptor α is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res, 2008, 68:8805-8812.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部